(AXLA) CEO Bill Hinshaw on Q2 Results - Earnings Call Transcript. 75 per share, before deducting underwriting discounts. 9% in Session Zacks Equity Research - Zacks Investment Research - Thu Aug 13, 7:49AM CDT. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. and changed its name to Axcella Health Inc. &0183;&32;Axcella’s common stock is expected to begin trading on The Nasdaq Global Market on, under the ticker symbol “AXLA.
The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group. (US:AXLA) has 129 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). The stock, one that is focused on the biotechnology space, is presently trading at .
(NASDAQ:AXLA) has earned an average rating of “Buy” from the eleven research firms that are covering the stock, MarketBeat reports. Legal Name Axcella Health, Inc. Common Stock: US: USD: May : Biography. AXLA currently has a short float of 1. Company Analysis and Financial Data Status. AXLA gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.
Market Cap Shares in Issue Float Revenue Profit/Loss EPS. ist ein Biotechnologieunternehmen. 13% up with the monthly amount drift of 37. Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving. This stock, which remained volatile and traded within the range of . Where is Axcella Health stock heading?
Largest shareholders include Flagship Ventures Management, axcella stock Inc. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The move came on solid volume too with far more shares changing hands than in a normal session. The company belongs in the Biotechnology industry, Healthcare sector and employs 64 people. ; The Axcella Health 52-week high stock price is 7.
Other discussions about Axcella Health Inc Stock New thread Forum. AXLA was a big mover last session, as the company saw its shares rises more than 5% on the day. Axcella Health market value as of Novem is .
(NASDAQ:AXLA) 5 of the analysts out axcella stock of 5 who provided ratings for Axcella Health Inc. Two analysts have rated the stock with a. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. As of this writing, the stock is at . 52M with average trading volume of 357. AXLA has traded in a range of .
Compiled here, all relevant comments and discussions regarding the AXLA Stock. (NASDAQ: AXLA) stock closed at 5. With this latest performance, AXLA shares gained by 37.
Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Zacks Equity Research - ZACKS - Thu Aug 13, 7:49AM CDT. Get instant access to a free live streaming chart of the Axcella Health Inc Stock.
Axcella Health Inc: AXLA: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded ; 0. 75% from the stock’s previous close. 60% and public float of 27. 0 MILLION SHARES OF COMMON STOCK - SEC axcella stock FILING Source: ly/3fFrU0l) Further company coverage: BRIEF-Axcella. 5 per share at the end axcella stock of the most recent trading day (a -2.
is a biotechnology company, which engages in the research and development axcella stock of novel multifactorial interventions to support health and address dysregulated metabolism across a. 65: Bid Price Ask Price Spread News; 5. Chardan Capital’s price objective indicates a potential axcella stock upside of 178.
&0183;&32;Axcella Health (NASDAQ:AXLA)‘s stock had its “buy” rating reiterated by analysts at Chardan Capital in a note issued to investors on Thursday, AnalystRatings. , Fmr Llc, Harbourvest Partners Llc, FDGRX - Fidelity Growth Company Fund, BlackRock Inc. 30% and seems well in a long time frame. Axcella Health (AXLA) Looks Good: Stock Adds 5.
7% above the current share price. 65: 07:00:00: Open Price Low Price High Price Close Price Previous Close; 5. All financial data provided by Standard & Poor's Capital IQ.
AXLA was a big mover last axcella stock session, as the company saw its shares rise nearly 6% on the day. Axcella Health, Inc. Our overall hedge fund sentiment score for AXLA is 25. &0183;&32;Axcella Health Inc. 41K shares and market capitalization of 206. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Information is provided 'as-is' and solely for info. 00 target price on the stock.
81 in the last 1 year. 30% in over the last four-week period, additionally plugging by 24. 78--Last Trade Time Type Quantity Stock Price Currency-0: $ 5. &0183;&32;Axcella Health Inc. Axcella Health (AXLA) share price, charts, trades & the UK's most popular discussion forums. Axcella Health (AXLA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
65: USD: Axcella Health Financials. Collectively, these companies sit at 1 in the Zacks Sector Rank. 79% over the last 6 months – not to mention a drop of -15. The company was founded by Noubar B.
Any forward-looking statements contained in this press release. ” All of the common stock in the offering is being offered by. What this means: Axcella Health Inc (AXLA) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system.
Historical daily share price chart and data for Axcella Health since adjusted for splits. (AXLA) is making a move down in the market today. Stock Symbol NASDAQ:AXLA ; Company Type For Profit; Contact Email com; Phone Number; Axcella Health is pioneering revolutionary new medicines with a focus on amino acid homeostasis. Here's Why We're Not At All Concerned With Axcella Health's (NASDAQ:AXLA) Cash Burn Situation. (NASDAQ:AXLA) is not the least popular stock in this group but hedge fund interest is still below average. Axcella Health is one of 888 individual stocks in the Medical sector.
Seeking Alpha - 1 month ago. , a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. stocks as a “buy” while 0 as axcella stock overweight, 0 rated it as hold and 0 as sell. (AXLA) stock quote, history, news and other vital information to help you with your stock trading and investing. Is a component of indices and it is traded on NASDAQ exchange. Axcella Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option. Axcella Health Stock analysis including Axcella Health investment evaluation, stock information, alerts, predictive tools such as market volatility and liquidity estimators and more. The move came on solid volume with far more shares changing hands than in a normal session.
The all-time high Axcella Health stock closing price was 14. Axcella Health beats Vaxart on 8 of the 13 factors compared between the two stocks. Over the last week, AXLA shares are 11. Find the latest Axcella Health Inc. , Vanguard Group Inc, Artal. Axcella Health (AXLA) stock price, charts, trades & the US's most popular discussion forums.
&0183;&32;How has AXLA stock performed recently? The company has discovered more than 2,000 diseases with amino acid imbalances and developed a systems pharmacology approach to restore. 86% in the past year of trading. Axcella disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. The latest closing stock price for Axcella Health as of Novem is 4. 08:18:Free Membership Login. Data Last Updated. Axcella Health Inc.
Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. Axcella’s Late-Breaker Data from AXAClinical Study Presented at the EASL Digital International Liver Congress. 11 in the past one-month time frame, witnessed a sharp increase yesterday. Interactive chart of historical stock value for Axcella Health over the last 10 years. These institutions hold a total axcella of 30,637,372 shares. Webull offers Axcella Health AXLA historical stock prices, in-depth market analysis, NASDAQ:AXLA real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart.
Vaxart Company Profile. 23 after tumbling. (AXLA) CEO Bill Hinshaw on Q2 Results - Earnings Call Transcript. 94 below current price. The average price we get from analysts is . Wall Street analysts weigh in with their price targets at Analyst Ratings Network.
4% of Axcella Health shares are held by insiders. Today's Range Now: . There's no doubt that money can be made by owning shares of unprofitable businesses. The company was formerly known as Newco LS16, Inc.
They presently have a . 48 % change compared to the prior day closing price) with a volume of 45. Free forex prices, toplists, indices and lots more.
In addition, Axcella has granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of common stock at the public offering price, less the underwriting discounts and. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. 50 Day Range MA: . Das Unternehmen konzentriert sich auf die Forschung und Entwicklung von multifaktoriellen Interventionen zur Unterst&252;tzung der Gesundheit und zur Bek&228;mpfung eines dysregulierten Stoffwechsels bei einem breiten Spektrum von Verbrauchern. Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of .
The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines. View today's stock price, news and analysis for Axcella Health Inc. 83%) XOMA (XOMA) Catches Eye: Stock.
03 in the past one-month time frame, witnessed a sharp increase yesterday. * AXCELLA HEALTH INC FILES FOR OFFERING OF UP TO 11. AXLA's 73 means that it ranks higher than 73% of stocks.
-> Lamr stock price today
-> Southern company stock report